


AI Biotech Fund Revenue
Investment Management • • 1-10 Employees
AI Biotech Fund revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Investment Management industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Key Contact at AI Biotech Fund
David Attias
Director
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 5231 |
| Employees | 1-10 |
AI Biotech Fund Email Formats
AI Biotech Fund uses 1 email format. The most common is {first name} (e.g., john@aibiotechfund.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@aibiotechfund.com | 100% |
About AI Biotech Fund
The AI Biotech Fund is a specialised, data-driven investment fund combining artificial intelligence and fundamental analysis to uncover mispriced opportunities in the biotech sector. We focus on companies approaching key clinical trial catalysts — where rigorous analysis and predictive modelling can create asymmetric outcomes. Our proprietary AI model incorporates Opyl’s TrialKey platform — an engine trained on over 450,000 historical clinical trials to estimate the probability of success — and integrates traditional company and macro fundamentals to identify high-probability, high-impact events. These insights are complemented by deep fundamental research into mechanism of action, competitive landscape, and risk-reward profile, enabling conviction-weighted investment decisions. Designed for wholesale investors, the fund offers a disciplined strategy grounded in predictive analytics, active portfolio management, and rigorous due diligence — transforming complexity into opportunity.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
AI Biotech Fund has never raised funding before.
Frequently asked questions
4.8
40,000 users



